Oak Street Health, Inc.
OSHDelisted May 2, 2023- Industry
- Services-Health Services
- SEC CIK
- 0001564406
Oak Street Health, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on May 4, 2023; 273 institutions reported holding it in 13F filings for Q1 2023, worth $8.37B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Oak Street Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Oak Street Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wassong David | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Yadav Ravi | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Newlight Partners LP | Director, 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Newlight GP LLC | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| Newlight Harbour Point SPV LLC | 10% Owner | 0Indirect | May 4, 2023 | 0 |
| General Atlantic, L.P. | Director, 10% Owner | 0Indirect | May 2, 2023 | 0 |
| Gap Coinvestments III, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| Gap Coinvestments IV, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| GAP Coinvestments CDA, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic Genpar, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic Partners 93, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic Partners 100, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic (OSH) Interholdco, L.P. | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| General Atlantic (SPV) GP, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| GAP Coinvestments V, LLC | 10% Owner | 0Indirect | May 2, 2023 | 0 |
| Kusserow Paul B. K. | Director | 0 | May 2, 2023 | 0 |
| Dorsey Cheryl | Director | 0 | May 2, 2023 | 0 |
| Klapstein Julie D | Director | 0 | May 2, 2023 | 0 |
| Benjamin Regina M. | Director | 0 | May 2, 2023 | 0 |
| Kaushal Mohit | Director | 0 | May 2, 2023 | 0 |
| Pykosz Michael T | Chief Executive Officer | 0Indirect | May 2, 2023 | 0 |
| Price Geoffrey M | Chief Innovation Officer | 0Indirect | May 2, 2023 | 0 |
| Guenthner Robert | Chief Legal Officer | 0 | May 2, 2023 | 0 |
| Myers Griffin | Chief Medical Officer | 0Indirect | May 2, 2023 | 0 |
| Cook Timothy M | Chief Financial Officer | 0Indirect | May 2, 2023 | 0 |
| Keck Kim | Director | 0 | May 2, 2023 | 0 |
| Clem Brian | Chief Operating Officer | 0 | May 2, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2023 (view filing) | Apr 18 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $38.88 | −$1.94M | −1.3%3.88M after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Cook Timothy MChief Financial Officer | SSaleCommon Stock, $0.001 par value | −5.98K | $38.82 | −$232.1K | −0.4%1.46M after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −4.52K | $38.82 | −$175.3K | −0.1%3.88M after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −3.17K | $38.82 | −$123.0K | −0.6%489.3K after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $38.80 | −$1.94M | −1.3%3.88M after | |
| Apr 3, 2023 (view filing) | Mar 31 | 3 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −450.0K | $38.69 | −$17.4M | −10.4%3.88M after | 2 lots |
| Mar 22, 2023 (view filing) | Mar 21 | 1 day | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $35.73 | −$1.79M | −1.3%3.88M after | 10b5-1 |
| Mar 21, 2023 (view filing) | Mar 17 | 4 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −37.9K | $35.63 | −$1.35M | −1.0%3.87M after | 10b5-1 |
| Mar 17, 2023 (view filing) | Mar 15-16 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −81.7K | $35.62 | −$2.91M | −2.1%3.87M after | From original2 lots10b5-1 |
| Mar 13, 2023 (view filing) | Mar 9 | 4 days | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −8.25K | $35.43 | −$292.3K | −1.9%432.8K after | |
| Mar 9, 2023 (view filing) | Mar 7 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $35.54 | −$1.78M | −1.3%3.82M after | |
| Feb 27, 2023 (view filing) | Feb 23 | 4 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −7.73K | $35.48 | −$274.2K | −0.2%3.87M after | |
| Feb 27, 2023 (view filing) | Feb 23 | 4 days | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −10.8K | $35.47 | −$381.9K | −2.4%441.0K after | 2 lots |
| Feb 27, 2023 (view filing) | Feb 23 | 4 days | Cook Timothy MChief Financial Officer | SSaleCommon Stock, $0.001 par value | −5.11K | $35.48 | −$181.2K | −0.4%1.35M after | |
| Feb 23, 2023 (view filing) | Feb 21-22 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −173.0K | $35.53 | −$6.15M | −4.3%3.87M after | 2 lots |
| Feb 13, 2023 (view filing) | Feb 10 | 3 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −7.41K | $35.60 | −$263.9K | −0.2%3.87M after | |
| Feb 13, 2023 (view filing) | Feb 9 | 4 days | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −8.25K | $35.26 | −$290.9K | −1.8%451.8K after | |
| Feb 9, 2023 (view filing) | Feb 7 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −400.0K | $34.07 | −$13.6M | −9.4%3.87M after | |
| Feb 3, 2023 (view filing) | Feb 2 | 1 day | Cook Timothy MChief Financial Officer | SSaleCommon Stock, $0.001 par value | −1.48K | $28.49 | −$42.2K | −0.1%1.36M after | |
| Feb 3, 2023 (view filing) | Feb 2 | 1 day | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −592 | $28.85 | −$17.1K | −0.1%460.0K after | |
| Jan 27, 2023 (view filing) | Jan 26 | 1 day | Guenthner RobertChief Legal Officer | SSaleCommon Stock, $0.001 par value | −8.25K | $28.36 | −$234.0K | −1.8%460.6K after | 2 lots |
| Jan 17, 2023 (view filing) | Jan 13 | 4 days | Clem BrianChief Operating Officer | SSaleCommon Stock, $0.001 par value | −20.8K | $30.15 | −$627.4K | −4.3%468.8K after | |
| Jan 13, 2023 (view filing) | Jan 12 | 1 day | Clem BrianChief Operating Officer | SSaleCommon Stock, $0.001 par value | −6.60K | $30.02 | −$198.2K | −1.3%489.6K after | |
| Jan 12, 2023 (view filing) | Jan 10 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $29.74 | −$1.49M | −1.3%3.82M after | |
| Jan 12, 2023 (view filing) | Jan 10-11 | 2 days | Clem BrianChief Operating Officer | SSaleCommon Stock, $0.001 par value | −50.2K | $29.68 | −$1.49M | −9.2%496.2K after | 3 lots |
| Jan 5, 2023 (view filing) | Jan 3 | 2 days | Clem BrianChief Operating Officer | SSaleCommon Stock, $0.001 par value | −5.00K | $24.02 | −$120.1K | −0.9%546.3K after | 2 lots |
| Dec 5, 2022 (view filing) | Dec 1 | 4 days | Clem BrianChief Operating Officer | SSaleCommon Stock, $0.001 par value | −5.00K | $21.83 | −$109.2K | −0.9%551.3K after | |
| Nov 2, 2022 (view filing) | Nov 1 | 1 day | Clem BrianChief Operating Officer | SSaleCommon Stock, $0.001 par value | −5.00K | $20.57 | −$102.8K | −0.9%556.3K after | |
| Oct 5, 2022 (view filing) | Oct 3-4 | 2 days | Clem BrianChief Operating Officer | SSaleCommon Stock, $0.001 par value | −7.43K | $24.48 | −$181.9K | −1.3%561.3K after | 3 lots |
| Sep 23, 2022 (view filing) | Sep 22 | 1 day | Myers GriffinChief Medical Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $26.32 | −$1.32M | −1.0%4.85M after | 3 lots |
| Sep 16, 2022 (view filing)4:49 PM ET | Sep 16 | Same day | Newlight Partners LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 | −838.5K | $24.72 | −$20.7M | −2.5%32.7M after | |
| Sep 9, 2022 (view filing) | Sep 8 | 1 day | Myers GriffinChief Medical Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $27.39 | −$1.37M | −1.0%4.90M after | 3 lots |
| Sep 7, 2022 (view filing) | Sep 6 | 1 day | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −40.0K | $24.90 | −$996.1K | −3.6%1.07M after | 2 lots |
| Sep 6, 2022 (view filing) | Sep 1 | 5 days | Clem BrianChief Operating Officer | SSaleCommon Stock, $0.001 par value | −10.0K | $25.39 | −$253.9K | −1.7%568.8K after | 4 lots |
| Aug 26, 2022 (view filing) | Aug 25 | 1 day | Myers GriffinChief Medical Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $28.95 | −$1.45M | −1.0%4.95M after | |
| Aug 25, 2022 (view filing) | Aug 23 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −40.0K | $25.71 | −$1.03M | −3.5%1.11M after | 2 lots |
| Aug 19, 2022 (view filing)5:33 PM ET | Aug 19 | Same day | Newlight Partners LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, par value $0.001 | −7.00M | $24.72 | −$173.0M | −17.3%33.5M after | |
| Aug 19, 2022 (view filing) | Aug 17 | 2 days | Clem BrianChief Operating Officer | SSaleCommon Stock, $0.001 par value | −10.0K | $25.76 | −$257.6K | −1.7%586.5K after | 4 lots |
| Aug 15, 2022 (view filing) | Aug 11 | 4 days | Myers GriffinChief Medical Officer | SSaleCommon Stock, $0.001 par value | −50.0K | $29.08 | −$1.45M | −1.0%5.00M after | 2 lots |
| Aug 12, 2022 (view filing) | Aug 11 | 1 day | Pykosz Michael TChief Executive Officer | SSaleCommon Stock, $0.001 par value | −15 | $29.32 | −$439.8 | 0.0%7.19M after | |
| Aug 10, 2022 (view filing) | Aug 9 | 1 day | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −40.0K | $29.08 | −$1.16M | −3.4%1.15M after | |
| Aug 8, 2022 (view filing) | Aug 4-8 | 4 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −199.9K | $30.27 | −$6.05M | −14.3%1.19M after | 3 lots |
| Aug 4, 2022 (view filing) | Aug 2 | 2 days | Clem BrianChief Operating Officer | SSaleCommon Stock, $0.001 par value | −40.0K | $30.00 | −$1.20M | −6.3%596.5K after | |
| Aug 4, 2022 (view filing) | Aug 2-3 | 2 days | Pykosz Michael TChief Executive Officer | SSaleCommon Stock, $0.001 par value | −160.7K | $30.04 | −$4.83M | −2.2%7.19M after | 2 lots |
| Aug 4, 2022 (view filing) | Aug 2-3 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −150.1K | $30.03 | −$4.51M | −9.7%1.39M after | 2 lots |
| Jul 29, 2022 (view filing) | Jul 28 | 1 day | Myers GriffinChief Medical Officer | SSaleCommon Stock, $0.001 par value | −200.0K | $28.64 | −$5.73M | −3.8%5.05M after | 2 lots |
| Jul 27, 2022 (view filing) | Jul 26 | 1 day | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −40.0K | $27.97 | −$1.12M | −2.5%1.54M after | |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −150.0K | $21.20 | −$3.18M | −8.7%1.58M after | |
| Jul 14, 2022 (view filing) | Jul 12 | 2 days | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −62.8K | $22.41 | −$1.41M | −3.5%1.73M after | 2 lots |
| Jun 29, 2022 (view filing) | Jun 28-29 | 1 day | Price Geoffrey MChief Innovation Officer | SSaleCommon Stock, $0.001 par value | −97.2K | $18.55 | −$1.80M | −5.1%1.80M after | 4 lots |